Dear tred, if the Ebola scare continues to get out of hand, the gov't will step up and pay for drug supply. They've already done this for clinical testing and furthermore, have ultimately intended to build a stockpile of drugs found to work, so I'm not sure why you have such a hard time believing they'll pay now when the crisis is at hand. It's really mind boggling how you refuse to see this.
You'll be right if the Ebola crisis can remain contained in Africa (doubtful at the moment), but if not, you're going to be very wrong. The gov't isn't going to sit around and watch people die, particularly when it already has a history of paying for the R&D on Ebola drugs. It's common sense.
TKMR's drug is also going to be used, and if the frontrunner right now is ZMapp. There isn't going to be one drug of choice. Could you at least try to be objective instead of just pumping for the sake of pumping? It doesn't help the stock price and makes you as suspicious as bashers.
Yes, I'm sure money problems were the cause of his depression. That's usually the reason people are depressed.
SPPI's history speaks for itself. Horrible management. Pumpy press releases. The whole enchilada. We'll have to agree to disagree, but I do hope you make money on it regardless.
Yeah, ICPT definitely has legs. NASH is a huge market.
I really like BLUE for its longterm prospects, but it is a somewhat risky play.
CMRX looks golden. They have a similar situation to SRPT wherein the anecdotal evidence that their main drug works is pretty compelling. Look up "Josh Hardy going home" on Google. This kid was about to die, until Chemerix's drug saved him. It's got a ways to go before finishing up its current trial, but it's a pretty safe longterm bet.
Yep, but probably not as quickly as this price movement is suggesting. I'd wager a sale is months away still. Still a good buy at these levels though.
Your ignorance and stubbornness on this issue is perplexing. There is money to be made. You keep insisting that no one will pay for it, which is absurd. It's not as if the gov't can force any of the companies with potential Ebola treatments to make more once their supply runs out. The money has to come from somewhere, and if one or more of the treatments is determined to be effective, it will. The WHO is finally realizing that they can't sit around idle anymore.
There won't be enough for just one company's supply to go around. Every company's supply is going to be used. Why is it so hard for people to understand that?
Likely true, easy. But I think if the toxicity continues to be shown once on the market (assuming drisa does make it to market), I think the parents will raise such a fuss that insurance companies will have to back down. Boys with DMD don't have a few months to see whether or not a drug is toxic, and the parents and advocacy groups will make this clear. Time is far too precious for them.
No, Gary, they aren't afraid of it. Just another conspiracy theory by you. Once SRPT's drug is tested on an infected patient, will you continue to have wild conspiratorial fantasies?
Fat chance. ZMapp didn't save the Spanish missionary, although he might have received it too late.
Secondly, SRPT has an Ebola drug as does GSK (I think through a partnership), BCRX, and I believe a Swiss company. You can be sure that all of these Ebola drugs will be tested. That being said, I think TKMR's Ebola drug is probably too toxic for many patients, and I wouldn't call it the lead horse by any stretch of the imagination. I doubt it will end up being the go-to drug. But my point is that there are plenty of options. Your bashing is rather poor.
I hold no position in TKMR and have not throughout this Ebola craze. I am, however, objective.
This sucks for obvious reasons. But for those who think SRPT's Ebola drug will be much ado about nothing, you should probably think again.
We'll have to agree to disagree. I don't think the Obama's association with Sarepta has affected the company in any way at all. That's too much of a stretch and far too conspiratorial for me. I believe in Occam's Razor most of the time. That is, the company has been held up due to its own history and various missteps by management.